ArticleACR open rheumatology2020

Adverse Effects of Low-Dose Methotrexate in a Randomized Double-Blind Placebo-Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial.

Kathleen M M Vanni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.